Engineering High-Efficiency Metabolic Flux for Sustainable Biomanufacturing and Specialty Chemicals. Pseudomonas putida is a versatile industrial powerhouse, renowned for its exceptional metabolic plasticity and robust tolerance to harsh environmental conditions. CD Biosynsis provides professional Pseudomonas putida Pathway Optimization Services to transform this resilient host into a high-performance microbial cell factory. By integrating metabolic engineering, enzyme engineering, and fine-tuned gene regulation, we optimize both native and heterologous pathways to achieve commercially viable titers for bioplastics, advanced biofuels, and novel biochemicals.
Get a Technical QuoteOur optimization platform is designed to navigate the complex metabolic network of P. putida, ensuring maximum carbon flux redirection toward your target molecule. We focus on enhancing biosynthetic throughput while minimizing metabolic drag.
| Service Tier | Technical Strategy | Primary Application | Standard Deliverables |
|---|---|---|---|
| Native Pathway Tuning | Promoter & RBS engineering | Custom biopolymers (e.g., PHA) | Optimized strains + Polymer data |
| Heterologous Expression | Pathway gene expression tuning | Mevalonate & Isoprenoid production | High-titer strains + Titer report |
| Industrial Biocatalysis | Multi-enzyme coordination | Novel sugar alcohols & Fine chemicals | Catalytic activity data + Scale-up info |
| Waste-to-Value Rewiring | Systems biology & Biodegradation | Circular economy & Renewable feedstocks | Transformation efficiency reports |
1. Metabolic Network Modeling
2. Pathway Construction
3. Flux Optimization & Balancing
4. Scale-up Characterization
Utilizing in silico tools to identify bottlenecks and predict the impact of pathway interventions.
Formal project proposal and Mutual NDA signing.
Deploying scarless genomic integration tools to insert multi-gene synthetic circuits or metabolic clusters.
Assembly of both native and synthetic pathway modules.
Fine-tuning expression levels of rate-limiting enzymes to ensure seamless transition of intermediates.
Minimizing the buildup of metabolic byproducts to enhance host fitness.
Characterizing pathways under industrial fermentation conditions, focusing on TYR (Titer, Yield, Rate).
Final delivery of optimized pathways and comprehensive analytical validation reports.
To deliver world-class results, our technical team continuously monitors and benchmarks our protocols against landmark research in the field. These studies showcase the flexibility of engineered P. putida.
Production of bio-plastics requires precision at the molecular level. By engineering native and synthetic pathways in P. putida, researchers successfully inserted specific monomers into polymer chains. This allowed for the production of "tailored" PHA with customized thermal properties, providing a sustainable alternative to petroleum plastics.
(Reference: Engineering Native and Synthetic Pathways, 2020)
Mevalonate is a vital precursor for high-value isoprenoids. Technical benchmarks demonstrate that precisely tuning the expression levels of key heterologous genes can significantly enhance mevalonate titers in P. putida. This strategy ensures efficient biosynthetic throughput, establishing a robust platform for perfumes and pharmaceuticals.
(Reference: Production of mevalonate in P. putida, 2023)
Building new biosynthetic pathways requires seamless enzyme coordination. Using P. putida as a cell factory, researchers optimized the expression of a multi-enzyme complex to produce a novel sugar alcohol. This highlights the ability to combine metabolic and enzyme engineering for commercially viable specialty biochemicals.
(Reference: Engineering the production of a novel sugar alcohol, 2021)
P. putida excels at processing diverse and inexpensive renewable raw materials. Systems biology approaches have been used to optimize its metabolic diversity for the degradation of industrial waste streams, transforming biowaste into high-value drugs and chemicals within the global circular bioeconomy.
(Reference: Industrial biotechnology of P. putida, 2020)
1. Why is P. putida preferred for isoprenoid or mevalonate production?
P. putida possesses a high natural tolerance to hydrophobic molecules and a robust energy metabolism. This makes it a superior host for producing precursors like mevalonate, which can be toxic to other microbial hosts.
2. Can you optimize pathways for specific industrial waste streams?
Absolutely. We specialize in rewiring the native biodegradation pathways of P. putida to allow for the efficient conversion of renewable feedstocks and industrial biowaste into high-value products.
3. What is "Tailored PHA" production?
Unlike standard bioplastics, tailored PHA engineering allows us to control the monomeric composition. By optimizing the pathway, we can produce plastics with specific flexibility, melting points, or durability tailored for your application.
4. How do you balance the expression of multiple enzymes in a heterologous pathway?
We use a combination of metabolic modeling and promoter/RBS libraries. This ensures that no single enzyme creates a bottleneck or leads to toxic intermediate buildup, ensuring efficient metabolic flux.
5. What is the typical development cycle for pathway optimization?
A standard optimization project—including network modeling, construction, and titer validation—typically takes 10 to 16 weeks, depending on the complexity of the pathways involved.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.